RW6VBTB: Cordis Railway 6F Sheathless Access System w/Bare SS Mini Access Wire

Sign in to add this product to your favorites!
| Price: | $39.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 5 eaches |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 12 hours 40 minutes and choose overnight shipping at checkout. |
Additional Details
Cordis Railway Sheathless Access System
Cordis Railway 6F Sheathless Access System w/Bare SS Mini Access Wire
Product Code: RW6VBTB
- Mini Access Wire: Bare Stainless Steel
- Needles Included: IV Cannula and Bare Needle
- Vessel Dilator: 6F Green
- Recommended Guide Catheter Compatibility: 6F Cordis Vista Brite Tip
AccessGUDID Info
- FDA Product Code: DYB
- FDA Product Code Name: INTRODUCER, CATHETER
- GMDN Term Code: 58865
- GMDN Term Name: Vascular catheter introduction set, nonimplantable
- GMDN Term Description: A collection of nonimplantable, invasive devices intended to provide percutaneous vascular access to enable introduction of a catheter (not included) into the vascular system. It includes a non-steerable introducer sheath with an inner obturator/dilator, and typically an additional access device(s) [e.g., guidewire, introducer needle, syringe, additional dilators] which may include a haemostatic valve to control blood loss, usually to enable arterial access. This is a single-use device.
Manufacturer
Cordis is a global leader in interventional cardiovascular technologies, with a strong legacy in developing minimally invasive solutions for the treatment of coronary and peripheral vascular disease. Their portfolio includes diagnostic and interventional catheters, guidewires, and balloon angioplasty systems, as well as stents like the SMART Control and S.M.A.R.T. Flex for peripheral use. Cordis also offers radial access products and closure devices to support efficient and safe procedures. With a renewed focus on innovation and global expansion, Cordis continues to provide trusted tools that help physicians deliver effective, streamlined care in both coronary and endovascular interventions.
IN-DATE